{
    "PMC": "2150093",
    "DOI": "10.1038/bjc.1998.149",
    "PMID": "9528832",
    "PMCID": "PMC2150093",
    "title": "Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma.",
    "year": 1998,
    "source_url": "https://europepmc.org/article/PMC/PMC2150093",
    "source": "MED",
    "abstract_text": "Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants.",
    "full_text": "pmc Br J Cancer Br J Cancer British Journal of Cancer 0007-0920 1532-1827 Nature Publishing Group 2150093 9528832 Research Article Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma. Mayr B. P\u00c3\u00b6tter E. Goretzki P. R\u00c3\u00bcschoff J. Dietmaier W. Hoang-Vu C. Dralle H. Brabant G. Abteilung Klinische Endokrinologie, Medizinische Hochschule Hannover, Germany. 3 1998 77 6 903 906 https://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article\u2019s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article\u2019s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ . Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants. Images Figure 2 Figure 3",
    "full_text_abstract": "Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants. Images Figure 2 Figure 3"
}